about us
We see the monumental innovation being developed by biotech companies everyday, and know firsthand the significance and impact of a successful clinical trial. Our focus is to ensure you have the right technology and accurate data to make that happen.
our story
Condor is building a world where finance accelerates human progress in medicine.
Michael, Jennifer’s father got an extra year of quality life due to Keytruda.
How it started
First-hand, on-the-ground experience.
Our CEO began her career in accounting as a CPA and auditor for Ernst & Young before transitioning into finance and operations leadership at biotech organizations. She solved the clinical financial management problems firsthand at several organizations.
The Condor vision
A mission to make life-saving treatments more accessible for everyone.
During her consulting work in biopharma, Jen was personally impacted by family and loved ones at the intersection of life, death, and clinical trials, making it her mission to help the innovators responsible for clinical advancements. She partnered with John YS to build a team equipped to create cutting edge, easy to use software that empowers organizations to bring more life-saving therapies to market without being held back by billions of dollars lost in obscure data and financial processes.
Ainsley, pictured above, with her father Steven, is here today because her father participated in a trial for Xpovio.
Our investors
Backed by top-tier investors.
our team
We're a team of driven experts, world-class investors, and industry leaders.
Join the team